We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Ozelle Presents AI-Assisted Hematology and Cell Morphology Analysis

By LabMedica International staff writers
Posted on 16 Nov 2026

Ozelle showcases its AI-assisted hematology analyzers and diagnostic workflow solutions at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. More...

The company highlights its O-Cyte 1 automated hematology analyzer, alongside other systems integrating cell morphology analysis, immunoassay, and clinical chemistry testing. The technologies are designed to support routine laboratory testing and decentralized diagnostic workflows.

Among the featured products is the O-Cyte 1, which combines complete blood count (CBC) testing with 7-part white blood cell differentiation and AI-assisted cell morphology analysis. The analyzer integrates high-resolution cell imaging and automated cell classification, allowing laboratory professionals to review individual cell images alongside numerical results when further evaluation is required.

The O-Cyte 1 supports a throughput of up to 60 tests per hour as a standalone analyzer, with capacity expandable to 360 tests per hour through six connected units. This modular configuration enables laboratories to adjust testing capacity according to workload. The system is designed to accommodate different laboratory volumes while maintaining access to AI-assisted morphology analysis.

The analyzer also incorporates an integrated reagent kit and consumable-contained fluid-contact components to simplify reagent handling and routine maintenance. Built-in self-checks and replaceable modules support troubleshooting and servicing, while the modular design is intended to reduce operational complexity and facilitate technical support across laboratory environments.

Alongside the O-Cyte 1, Ozelle presents the EHBT-75 automated hematology analyzer, which combines 7-part white blood cell differentiation with cell imaging and morphology analysis. The company also features the EHBT-50, a compact multifunctional platform integrating hematology, immunoassay, and dry biochemistry testing to address diagnostic requirements in different clinical settings.

Ozelle also highlights Open Dx, its AI Workbench designed to support AI-assisted report review and diagnostic result sharing. The software complements the company's hematology analyzers by providing tools for reviewing and managing test information. Together, these technologies are intended to support laboratory workflows that combine automated testing, cell morphology assessment, and digital data management.

The exhibition reflects Ozelle's focus on integrating AI-assisted cell classification with scalable hematology testing and simplified instrument maintenance. By combining numerical blood analysis with reviewable cell images, the company aims to support laboratory professionals in evaluating hematology results while accommodating varying testing volumes and operational requirements.

Ozelle exhibits at Booth D63 in Hall 1, where visitors can explore its hematology analyzers, multifunctional diagnostic platforms, and digital workflow solutions. The company uses its participation at MEDICA 2026 to engage with laboratory professionals and distribution partners and discuss applications for its diagnostic technologies across different healthcare environments.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Unlike conventional molecular methods, VedaBio\'s CRISPR-based technology detects targets without requiring amplification (Photo courtesy of Veda Bio)

Target-Amplification-Free CRISPR Platform Demonstrates Molecular Detection in Under 10 Minutes

Molecular testing plays an important role in clinical diagnostics, but conventional workflows often require time-consuming procedures and specialized equipment, limiting their use outside centralized laboratories.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.